PENNSAUKEN, N.J., May 19, 2010 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (Nasdaq:RCMT) today announced the opening of its European Headquarters in Cork, Ireland to service its multinational clients in the Life Sciences sector. After several years of growth in its Life Sciences practice in North America, RCM is entering the European market primarily to expand its regulatory and information technology services globally. "We selected Ireland because it is one of the leading international locations for the Life Sciences industry. Many of the largest pharmaceutical, biotech and medical device manufacturing companies have located their facilities in Ireland. We believe the European community is an important geographical market extension to our existing operations offering us a local presence and opportunities for future growth," commented Leon Kopyt, RCM's Chairman and CEO. RCM's office is located at Building 1000, City Gate, Mahon, Cork, Ireland. Mr. Fearghal Downey is the General Manager - Europe and can be reached at (353) 21-240-9049 or by email at Fearghal.firstname.lastname@example.org. About RCM RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services . RCM is an innovative leader in the design, development and delivery of these solutions to commercial and government sectors for nearly 40 years. RCM's offices are located in major metropolitan centers throughout North America. Additional information can be found at www.rcmt.com . About RCM Life Sciences Solutions RCM is a recognized national leader in regulatory compliance services providing a broad range of consulting and management services to pharmaceutical, biotech and medical device manufacturers. RCM supports its clients' regulatory compliance efforts with comprehensive expertise in quality management systems, eCTD, pharmacovigilance, computer systems validation, network qualification, lab equipment and process control validation as well as enterprise application software implementation. Our services are specifically designed to mitigate risk and reduce time to deployment. For additional information, please visit http://www.rcmt.com/lifesciencessolutions.aspx . The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. Forward looking statements include, but are not limited to, those relating to demand for the Company's services, expected demand for our services and expectations regarding our revenues, the Company's ability to continue to utilize goodwill, to continue to increase gross margins, to achieve and manage growth, to develop and market new applications and services, risks relating to the acquisition and integration of acquired businesses, the ability of the Company to consummate acquisitions as to which it executes non-binding letters of intent, demand for new services and applications, timing of demand for services, industry strength and competition and general economic factors. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission.
CONTACT: RCM Technologies, Inc. Corporate Contacts: William Gargano, Group SVP - IT Division (973) 658-3029 Fearghal Downey, General Manager - Europe +353 21 2409049 Mobile +353 87 2370805 email@example.com